BioSpace News Archive

Drug Development

Regeneron and Sanofi‘s Blockbuster Drug Hits the Mark in Two Phase III trials

Shares of Regeneron jumped more than 5 percent Monday after the company announced that its blockbuster drug Dupixent (dupilumab) hit the mark in two Phase III trials studying the drug as a treatment for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps.

October 17, 2018
·
3 min read
·
Alex Keown
Business

With $54 Million in Hand, Startup CuraSen Takes Aim at Parkinson’s and Alzheimer’s

San Mateo, Calif.-based startup CuraSen Therapeutics surged forward this morning with $54.5 million in Series A funding and a leadership team that includes executives from Afferent Pharmaceuticals, a company acquired by Merck in 2016 for $1.2 billion.

October 17, 2018
·
2 min read
·
Alex Keown
Drug Development

Neurana Pharmaceuticals to Present Tolperisone Phase 1 Clinical Data at the 2018 ACR/ARHP Annual Meeting

Presentation will highlight data demonstrating the non-sedating effects of tolperisone

October 17, 2018
·
2 min read
Business

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

CuraSen Therapeutics, Inc., a privately held biotechnology company focused on developing therapies to treat neurodegenerative diseases, today announced the closing of a $54.5 million Series A financing.

October 17, 2018
·
3 min read
Business

Pharmacy Quality Solutions Expands to Canadian Retail Pharmacy

Pharmacy Quality Solutions (PQS) today announced it will work with Loblaw Companies Limited, one of Canada’s largest retail pharmacy networks with Shoppers Drug Mart, PharmaPrix, Loblaw Pharmacy and DRUGStore Pharmacy and CENTRESante locations,

October 17, 2018
·
2 min read
Bio NC

New Pharmaceutical Industry Report Provides Blueprint for Creating an Effective Field Medical Team for Rare Diseases

An effective field-based medical team is especially crucial for rare disease products.

October 17, 2018
·
2 min read
Genetown

Echosens Observes October 2018 Liver Cancer Awareness Month: Know Your Risk for Nonalcoholic Fatty Liver Disease – A Looming National Epidemic

In support of Liver Cancer Awareness Month alongside the American Liver Foundation, Echosens calls for increased awareness of non-alcoholic fatty liver disease (NAFLD) and its more severe form called non-alcoholic steatohepatiti

October 17, 2018
·
3 min read
Job Trends

Questions to Ask Candidates on Health Policy Posed by the Association of American Physicians and Surgeons (AAPS)

Healthcare is one of the biggest issues is the upcoming midterms. Reading websites and listening to speeches gives the impression that all are in favor of high-quality, affordable, accessible healthcare.

October 17, 2018
·
1 min read
BioMidwest

CIVCO Radiotherapy Introduces Multiple New Solutions that Improve the Patient Journey at ASTRO 2018 Annual Meeting

CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will introduce and demonstrate multiple new solutions and collaborative partnerships in booth #2833 at the American Society for Radiation Oncology

October 17, 2018
·
2 min read
Biotech Bay

AgileHealthInsurance.com: 2019 Affordable Care Act Rates Make Short-Term Health Insurance Plans More Attractive

Last week the Centers for Medicare & Medicaid Services (CMS) released a statement that 2019 Affordable Care Act (ACA) health plan prices will drop by 1.5% for silver plans (SLCSP), the middle tier of ACA plans.

October 17, 2018
·
5 min read